[ CAS No. 15839-70-0 ] {[proInfo.proName]}

Name: 15839-70-0|(((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) methyl) ((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl) dihydrogen diphosphate|98%
Brand: Ambeed
SKU: A1147716
Rating: 90 (35 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 15839-70-0 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 15839-70-0 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 15839-70-0 ]

SDS Specification

Alternatived Products of [ 15839-70-0 ]

Product Details of [ 15839-70-0 ]

CAS No. :	15839-70-0	MDL No. :	MFCD00870977
Formula :	C₁₆H₂₅N₅O₁₅P₂	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	-
M.W :	589.34	Pubchem ID :	-
Synonyms :	GDP-L-fucose	Chemical Name :	(((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) methyl) ((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl) dihydrogen diphosphate

Safety of [ 15839-70-0 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 15839-70-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 15839-70-0 ]

[ 15839-70-0 ] Synthesis Path-Downstream 1~88

1
guanosine 5'-diphospho-D-mannose [ No CAS ]
[ 15839-70-0 ]

Reference： [1]Journal of the American Chemical Society,1958,vol. 80,p. 4426
[2]Carbohydrate Research,2001,vol. 334,p. 97 - 103

2
[ 7390-53-6 ]
[ 16562-58-6 ]
[ 15839-70-0 ]

Reference： [1]Canadian Journal of Chemistry,1990,vol. 68,p. 1063 - 1071

3
β-L-Fucopyranosyl phosphate bis(tri-n-octylammonium) salt [ No CAS ]
Guanosine 5'-phosphoromorpholidate N,N'-dicyclohexyl-4-morpholine carboxamidinium salt [ No CAS ]
[ 15839-70-0 ]

Reference： [1]Tetrahedron Letters,1991,vol. 32,p. 6175 - 6178

4
[ 86733-47-3 ]
[ 15839-70-0 ]
[ 141612-83-1 ]

Reference： [1]Journal of the American Chemical Society,1992,vol. 114,p. 7321 - 7322

5
[ 143398-10-1 ]
[ 15839-70-0 ]
[ 143398-11-2 ]

Reference： [1]Journal of the American Chemical Society,1992,vol. 114,p. 7321 - 7322

6
[ 142810-05-7 ]
[ 15839-70-0 ]
[ 142800-36-0 ]

Reference： [1]Journal of the American Chemical Society,1992,vol. 114,p. 7321 - 7322

7
[ 15839-70-0 ]
C₄₇H₇₈N₄O₃₄ [ No CAS ]
C₅₃H₈₈N₄O₃₈ [ No CAS ]

Reference： [1]Carbohydrate Research,1997,vol. 305,p. 491 - 499

8
[ 15839-70-0 ]
4-methoxybenzyl O-(3-sulfo-β-D-galactopyranosyl)-(1->4)-O-(2-acetamido-2-deoxy-6-O-sulfo-β-D-glucopyranosyl)-(1->3)-O-β-D-galactopyranosyl-(1->4)-O-β-D-glucopyranoside disodium salt [ No CAS ]
4-methoxybenzyl O-(3-sulfo-β-D-galactopyranosyl)-(1->4)-O-[(α-L-fucopyranosyl)-(1->3)]-O-(2-acetamido-2-deoxy-6-O-sulfo-β-D-glucopyranosyl)-(1->3)-O-β-D-galactopyranosyl-(1->4)-β-D-glucopyranoside disodium salt [ No CAS ]

Reference： [1]Carbohydrate Research,1997,vol. 305,p. 501 - 509

9
[ 15839-70-0 ]
N-{(2S,3R,4R,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-((2R,3S,4R,5R,6R)-5-Acetylamino-4,6-dihydroxy-2-hydroxymethyl-tetrahydro-pyran-3-yloxy)-3,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-4-yloxy]-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl}-acetamide [ No CAS ]
C₂₈H₄₈N₂O₂₀ [ No CAS ]

Reference： [1]Carbohydrate Research,1997,vol. 305,p. 491 - 499

10
[ 15839-70-0 ]
C₇₁H₁₁₅N₁₁O₄₅S₂ [ No CAS ]
C₈₃H₁₃₅N₁₁O₅₃S₂ [ No CAS ]

Reference： [1]Carbohydrate Research,1997,vol. 305,p. 433 - 442

11
[ 64160-39-0 ]
[ 15839-70-0 ]
[ 56343-02-3 ]

Reference： [1]Carbohydrate Research,1996,vol. 286,p. 87 - 105

12
[ 15839-70-0 ]
[ 156521-67-4 ]
5-Methoxycarbonylhexyl 2-acetamido-2-deoxy-3-O-(α-L-fucopyranosyl)-4-O-(β-D-galactopyranosyl)-β-D-glucopyranoside [ No CAS ]

Reference： [1]Chemistry - A European Journal,1999,vol. 5,p. 3326 - 3340

13
[ 15839-70-0 ]
[ 211746-74-6 ]
5-Methoxycarbonylhexyl 2-acetamido-2-deoxy-3-O-(α-L-fucopyranosyl)-4-O-(3-O-[5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulo-pyrnuronic acid]-β-D-galactopyranosyl)-β-D-glucopyranoside [ No CAS ]

Reference： [1]Chemistry - A European Journal,1999,vol. 5,p. 3326 - 3340

14
[ 15839-70-0 ]
Methyl 3,6-di-O-{2-O-[4-O-(β-D-galactopyranosyl)-2-deoxy-2-acetamido-β-D-glucopyranosyl]-α-D-mannopyranosyl}-α-D-mannopyranoside [ No CAS ]
Methyl 3,6-di-O-(2-O-[2-acetamido-2-deoxy-3-O-{α-L-fucopyranosyl}-4-O-{β-D-galactopyranosyl}-β-D-glucopyranosyl]-α-D-mannopyranosyl)-α-D-mannopyranoside [ No CAS ]

Reference： [1]Chemistry - A European Journal,1999,vol. 5,p. 3326 - 3340

15
[ 15839-70-0 ]
Methyl 3,6-di-O-(2-O-[2-acetamido-2-deoxy-4-O-{3-O-(5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulo-pyranuronic acid)-β-D-galactopyranosyl}-β-D-glucopyranosyl]-α-D-mannopyranosyl)-α-D-mannopyranoside [ No CAS ]
Methyl 3,6-di-O-(2-O-[2-acetamido-2-deoxy-3-O-{α-L-fucopyranosyl}-4-O-(3-O-[5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulo-pyranuronic acid]-β-D-galactopyranosyl)-β-D-glucopyranosyl]-α-D-mannopyranosyl)-α-D-mannopyranoside [ No CAS ]

Reference： [1]Chemistry - A European Journal,1999,vol. 5,p. 3326 - 3340

16
[ 15839-70-0 ]
N³-Benzyloxycarbonyl-N¹-[3,6-bis-O-[(5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosylonic acid)-(2,3)-β-D-galactopyranosyl-(1,4)-2-acetamido-2-deoxy-β-D-galactopyranosyl]-β-D-galactopyranosyl]-β-alanine amide [ No CAS ]
C₇₉H₁₂₄N₆O₅₂ [ No CAS ]

Reference： [1]Chemistry - A European Journal,2000,vol. 6,p. 162 - 171

17
N,N'-diacetylchitobiose [ No CAS ]
[ 15839-70-0 ]
β-D-GlcNAc(1->4)-[α-L-Fuc(1->6)]-D-GlcNAc [ No CAS ]

Reference： [1]Chemistry - A European Journal,2001,vol. 7,p. 2390 - 2397

18
Lactose [ No CAS ]
[ 15839-70-0 ]
2'-O-fucosyllactose [ No CAS ]

Reference： [1]Carbohydrate Research,2001,vol. 334,p. 97 - 103
[2]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

19
[ 15839-70-0 ]
C₃₅H₅₉N₂O₂₄S^(1-)*Na⁽¹⁺⁾ [ No CAS ]
C₄₁H₆₉N₂O₂₈S^(1-)*Na⁽¹⁺⁾ [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27
[2]Chimia,2001,vol. 55,p. 268 - 274

20
[ 15839-70-0 ]
[ 177610-59-2 ]
C₄₀H₇₀N₂O₂₆S [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27
[2]Chimia,2001,vol. 55,p. 268 - 274

21
[ 15839-70-0 ]
[ 785765-22-2 ]
(2S) 3-cyclohexyl-2-O-{1-O-[(1R,2R) 2-O-(α-L-fucopyranosyl)cyclohexyl]β-D-galactopyranos-3-yl}propionic acid [ No CAS ]

Reference： [1]Chimia,2001,vol. 55,p. 268 - 274
[2]Chimia,2006,vol. 60,p. 23 - 27

22
[ 18186-48-6 ]
[ 15839-70-0 ]

Reference： [1]Carbohydrate Research,2001,vol. 334,p. 97 - 103
[2]Journal of the American Chemical Society,2008,vol. 130,p. 17593 - 17602

23
6-O-β-D-galactopyranosyl-D-galactose [ No CAS ]
[ 15839-70-0 ]
(3R,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-4,5-Dihydroxy-6-hydroxymethyl-3-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxymethyl]-tetrahydro-pyran-2,3,4,5-tetraol [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

24
N-acetyl-D-lactosamine [ No CAS ]
[ 15839-70-0 ]
O-(6-Desoxy-α-L-galactopyranosyl)-(1-2)-O-(β-D-galactopyranosyl)-(1-4)-2-acetamido-2-desoxy-D-glucopyranose [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

25
[ 20869-27-6 ]
[ 15839-70-0 ]
C₁₈H₃₂O₁₅ [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

26
<β-D-Gal-(1<*>3)>2-β-D-Gal-(1<*>4)-D-Glc [ No CAS ]
[ 15839-70-0 ]
C₃₀H₅₂O₂₅ [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

27
β-D-Galp-(1->3)-β-D-Galp-(1->3)-β-D-Galp-(1->3)-β-D-Galp-(1->4)-D-Glc [ No CAS ]
[ 15839-70-0 ]
C₃₆H₆₂O₃₀ [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

28
β-D-Galp-(1->3)-β-D-Galp-(1->3)-β-D-Galp-(1->3)-β-D-Galp-(1->3)-β-D-Galp-(1->4)-D-Glc [ No CAS ]
[ 15839-70-0 ]
C₄₂H₇₂O₃₅ [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

29
methyl β-D-galactopyranosyl-<1->3>-β-D-galactopyranoside [ No CAS ]
[ 15839-70-0 ]
[ 613243-53-1 ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

30
[ 117895-03-1 ]
[ 15839-70-0 ]
[ 684237-06-7 ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

31
[ 128443-50-5 ]
[ 15839-70-0 ]
[ 182276-49-9 ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

32
[ 144722-08-7 ]
[ 15839-70-0 ]
(2S,3S,4R,5S,6S)-2-[(2S,3R,4S,5R,6R)-2-((2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3-yloxy)-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yloxy]-6-methyl-tetrahydro-pyran-3,4,5-triol [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

33
[ 15839-70-0 ]
[ 7216-69-5 ]
[ 155911-53-8 ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

34
[ 15839-70-0 ]
[ 65207-55-8 ]
(2S,3S,4R,5S,6S)-2-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-2-((2R,3S,4R)-4-hydroxy-2-hydroxymethyl-3,4-dihydro-2H-pyran-3-yloxy)-6-hydroxymethyl-tetrahydro-pyran-3-yloxy]-6-methyl-tetrahydro-pyran-3,4,5-triol [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

35
[ 75669-79-3 ]
[ 15839-70-0 ]
[ 848566-17-6 ]

Reference： [1]Journal of the American Chemical Society,2005,vol. 127,p. 2040 - 2041

36
heptakis{6-deoxy-6-S-[7-(2-acetamido-4-O-(3-O-(5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosylonic acid)-β-D-galactopyranosyl)-2-deoxy-β-D-glucopyranosyl-oxy)-4-aza-3-oxo-heptyl]-6-thio}-cyclomaltoheptaose [ No CAS ]
[ 15839-70-0 ]
heptakis{6-deoxy-6-S-[7-(2-acetamido-4-O-(3-O-(5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosylonic acid)-2-O-(α-D-fucopyranosyl)-β-D-galactopyranosyl)-2-deoxy-β-D-glucopyranosyl-oxy)-4-aza-3-oxo-heptyl]-6-thio}-cyclomaltoheptaose [ No CAS ]

Reference： [1]Tetrahedron,2005,vol. 61,p. 1737 - 1742

37
(S)-2-[(2R,3S,4S,5R,6R)-3,5-Dihydroxy-2-hydroxymethyl-6-((1R,2R)-2-hydroxy-1-methyl-propoxy)-tetrahydro-pyran-4-yloxy]-3-phenyl-propionic acid [ No CAS ]
[ 15839-70-0 ]
(S)-2-{(2R,3S,4S,5R,6R)-3,5-Dihydroxy-2-hydroxymethyl-6-[(1R,2R)-1-methyl-2-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-propoxy]-tetrahydro-pyran-4-yloxy}-3-phenyl-propionic acid [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

38
C₄₃H₆₃N₃O₂₃ [ No CAS ]
[ 15839-70-0 ]
C₄₉H₇₃N₃O₂₇ [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

39
[ 122290-69-1 ]
[ 15839-70-0 ]
[ 122290-72-6 ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

40
[ 122290-73-7 ]
[ 15839-70-0 ]
[ 122290-74-8 ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

41
[ 15839-70-0 ]
[ 177610-44-5 ]
C₄₁H₇₁N₃O₂₅ [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

42
[ 15839-70-0 ]
[ 177610-49-0 ]
C₄₃H₇₂N₂O₂₆ [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

43
[ 15839-70-0 ]
[ 177610-57-0 ]
C₄₆H₇₂N₂O₂₅ [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

44
[ 15839-70-0 ]
[ 219484-16-9 ]
8-methoxycarbonyloctyl 5-N-acetyl-α-neuraminyl-(2->3)-β-D-galactopyranosyl-(1->4)-[α-L-fucopyranosyl-(1->3)]-2-deoxy-2-(methyl-β-D-glucohexopyranosyluronamide)-β-D-glucopyranoside [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

45
[ 15839-70-0 ]
[ 294677-28-4 ]
C₁₈H₃₂O₁₁ [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

46
[ 15839-70-0 ]
[ 888011-02-7 ]
(2S) 3-phenyl-2-O-{1-O-[(1R,2R) 2-O-(α-L-fucopyranosyl)cyclohexyl]β-D-galactopyranos-3-yl}propionic acid [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

47
[ 15839-70-0 ]
[ 786630-44-2 ]
(2R) 3-cyclohexyl-2-O-{1-O-[(1R,2R) 2-O-(α-L-fucopyranosyl)cyclohexyl]β-D-galactopyranos-3-yl}propionic acid [ No CAS ]

Reference： [1]Chimia,2006,vol. 60,p. 23 - 27

48
[ 904926-03-0 ]
[ 15839-70-0 ]
2'-azidoethyl α-L-fucopyranosyl-(1->2)-β-D-galactopyranosyl-(1->4)-[α-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranoside [ No CAS ]

Reference： [1]Carbohydrate Research,2006,vol. 341,p. 1447 - 1457

49
[ 904925-99-1 ]
[ 15839-70-0 ]
2'-azidoethyl α-L-fucopyranosyl-(1->2)-β-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-β-D-glucopyranoside [ No CAS ]

Reference： [1]Carbohydrate Research,2006,vol. 341,p. 1447 - 1457

50
[ 904925-99-1 ]
[ 15839-70-0 ]
2'-azidoethyl β-D-galactopyranosyl-(1->4)-[α-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-[α-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranoside [ No CAS ]

Reference： [1]Carbohydrate Research,2006,vol. 341,p. 1447 - 1457

51
[ 15839-70-0 ]
[ 338971-38-3 ]
2'-azidoethyl β-D-galactopyranosyl-(1->4)-[α-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranoside [ No CAS ]

Reference： [1]Carbohydrate Research,2006,vol. 341,p. 1447 - 1457

52
[ 15839-70-0 ]
[ 338971-38-3 ]
[ 904926-03-0 ]

Reference： [1]Carbohydrate Research,2006,vol. 341,p. 1447 - 1457

53
[ 15839-70-0 ]
[ 485388-17-8 ]
2-azidoethyl (5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulo pyranosylonic acid)-(2->3)-β-D-galactopyranosyl-(1->4)[(1->3)-α-L-fucopyranosyl]-2-acetamido-2-deoxy-β-D-glucopyranoside [ No CAS ]

Reference： [1]Carbohydrate Research,2006,vol. 341,p. 1447 - 1457

54
C₃₇H₃₇N₅O₁₈P₂ [ No CAS ]
[ 15839-70-0 ]

Reference： [1]Organic Letters,2007,vol. 9,p. 1227 - 1230

55
[ 15839-70-0 ]
[ 730971-20-7 ]
<i>N</i>-[6-hydroxymethyl-2-[2-(pyridin-2-ylamino)-ethoxy]-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-4-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide [ No CAS ]

Reference： [1]Organic and Biomolecular Chemistry,2006,vol. 4,p. 681 - 690

56
[ 131897-73-9 ]
[ 15839-70-0 ]

Reference： [1]Organic Letters,2007,vol. 9,p. 1227 - 1230

57
[ 140223-15-0 ]
[ 15839-70-0 ]

Reference： [1]Organic Letters,2007,vol. 9,p. 1227 - 1230

58
[ 15839-70-0 ]
α-L-Fucp-[α-D-Galp(1->3)](1->2)-β-D-Galp-(1->3)-α-GalpNAc-OMe [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2005,vol. 127,p. 2040 - 2041

59
[ 15839-70-0 ]
(2R,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-hydroxymethyl-3-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-hexane-1,2,3,5,6-pentaol [ No CAS ]

Reference： [1]Tetrahedron Asymmetry,2003,vol. 14,p. 2381 - 2386

60
[ 15839-70-0 ]
C₃₄H₅₈N₂O₂₅ [ No CAS ]

Reference： [1]Carbohydrate Research,1997,vol. 305,p. 491 - 499

61
[ 15839-70-0 ]
C₄₅H₇₅N₃O₃₃ [ No CAS ]

Reference： [1]Carbohydrate Research,1997,vol. 305,p. 491 - 499

62
GlcNAcβ(1,4)GlcNAcβ(1,4)GlcNAcβ(1,4)GlcNAcβ(1,4)GlcNAcβ(1,4)GlcNAc [ No CAS ]
[ 15839-70-0 ]
GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAc [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	Fuc-TV; at 20.0℃; for 120h;	N-Acetyl-chitohexaose (1.0 µmol, 5 mM) was fucosylated with <strong>[15839-70-0]GDP-Fuc</strong>ose (1.0 µmol, 5 mM) and 25 mU Fuc-TV at room temperature for 5 days. MALDI-TOF MS of the purified representative mixture of the product oligosaccharides showed that 31 % of N-acetyl-chitohexaose was fucosylated (Fig. 2B). The product saccharides were further purified in in HPAE-chromatography run isocratically with 40 mM NaOH (Fig 1B). The peak eluting at 7.09 min was pooled, was desalted and was further purified by gel filtration HPLC. The product heptasaccharide (195 nmol) showed in MALDI-TOF analysis 96 % of monofucosylated N-acetyl-chitohexaose, Glycan 6, and 4 % of N-acetyl-chitohexaose, Fig. 2C. The 1D 1H NMR spectrum (Table 2) shows the H1 signals in the GlcNAc5, the GlcNAc6 and the fucose units in Glycan 6, which are nearly identical with their counteparts in Glycan 4. This suggests that the Glycan 6 is GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAc. This notion is further supported by the identical H4-signals of the distal GlcNAc6 units and the fucose H5 resonances in the two glycans. The similarity of this latter pair of signals in the two glycans is particularly significant, because they are known to interact in Glycan 4 (see above), and are likely to be very sensitive to stuctural differences. Likewise, the similarity of fucose H5 signals in Glycan 6, and Glycan 4 speaks for the identity of the nonreducing area in these three saccharides

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 10

63
chitotriose [ No CAS ]
[ 15839-70-0 ]
GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAc [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
		Incubation of N-acetyl-chitotriose (1000 nmol, 5 mM) with <strong>[15839-70-0]GDP-fucose</strong> (600 nmol, 3 mM) and 1.4 mU of the enzyme for four days at 37C gave an oligosaccharide mixture. After ion exchange desalting, mild β-N-acetylhexosaminidase treatment, and repeated gel filtration HPLC runs, a sample of 221 nmol of purified fucosylated N-acetyl-chitotriose was obtained. MALDI-TOF MS revealed that the product contained 92 % of fucosylated N-acetyl-chitotriose and 7 % of N-acetyl-chitotriose. The 1D 1H-NMR-spectrum of the product was almost identical with that of Fuc-TV-generated Glycan 3. The ESI-MS-data of the Glycan 3 in reduced form, too, were identical to those obtained with reduced derivative of the Fuc-TV-generated Glycan 3 (not shown).

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 9

64
chitotriose [ No CAS ]
[ 15839-70-0 ]
Fuc₁GlcNAc₂ [ No CAS ]
GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAc [ No CAS ]
N,N'-diacetylchitobiose [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
		The oligosaccharide mixture, generated by incubation of N-acetyl-chitotriose (1000 nmol, 5 mM) with <strong>[15839-70-0]GDP-Fuc</strong> (1000 nmol, 5 mM) and 25 mU Fuc-TV at room temperature for 5 days was desalted and isolated by gel filtration HPLC. MALDI-TOF-MS revealed that the mixture contained 32 mol % fucosylated N-acetyl-chitotriose and 68 % N-acetyl-chitotriose. This mixture was subjected to the "mild treatment" with jack bean β-N-acetylhexosaminidase, which cleaved most of the surplus N-acetyl-chitotriose substrate but only a small amount of the fucosylated N-acetyl-chitotriose product. A representative sample of all oligosaccharides was isolated from a 5 % aliquot of the digest by using gel filtration HPLC. MALDI-TOF MS analysis of showed that it consisted of fucosylated N-acetyl-chitotriose 67 mol %, N-acetyl-chitotriose 7 %, Fuc1GlcNAc2 12 %, and N-acetyl-chitobiose 13 %. The monofucosylated N-acetyl-chitotriose was purified from the rest of the β-N-acetylhexosaminidase digest by gel filtration HPLC. MALDI-TOF-MS analysis of the purified Fuc1GlcNAc3, Glycan 3, revealed the presence of only a 5 % N-acetyl-chitotriose contamination. The total yield of the purified Glycan 3 was 191 nmol (19 %).

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 8

65
N,N',N'',N'''-tetraacetylchitotetraose [ No CAS ]
[ 15839-70-0 ]
GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAc [ No CAS ]
GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAcβ1-4GlcNAc [ No CAS ]
chitotriose [ No CAS ]
N,N'-diacetylchitobiose [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
8%; 50%; 6%		Incubation of N-acetyl-chitotetraose (1000 nmol, 5 mM) with <strong>[15839-70-0]GDP-Fuc</strong> (1000 nmol, 5 mM) and 25 mU human Fuc-TV at room temperature for 5 days, and isolation of the resulting oligosaccharide mixture by using gel filtration HPLC gave a product consisting of 32 mol % fucosylated N-acetyl-chitotetraose and 68 % of unreacted N-acetyl-chitotetraose (Fig. 2A). The mild treatment of the mixture with jack bean β-N-aceylhexosaminidase followed by chromatographic removal of the liberated from GlcNAc gave an oligosaccharide mixture consisting of Fuc1GlcNAc4 50 %, GlcNAc4 6 %, Fuc1GlcNAc3 8 %, GlcNAc3 14 %, GlcNAc2 22 mol %. The composition of this mixture implies that also the fucosylated N-acetyl-chitotetraose was cleaved much slower than N-acetyl-chitotetraose by the β-N-acetylhexosaminidase, confirming the analogous data on degradation of Glycan 3. The oligosaccharide mixture was then fractionated by gel filtration HPLC, yielding a purified product (225 nmol) that consisted of 93 mol % of fucosylated N-acetyl-chitotetraose and 7 % N-acetyl-chitotetraose.

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 9

66
N,N',N'',N'''-tetraacetylchitotetraose [ No CAS ]
[ 15839-70-0 ]
GlcNAcβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAcβ1-4GlcNAc [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	human milk Fuc-Ts; at 37.0℃; for 96h;Conversion of starting material;	N-Acetyl-chitotetraose (6.0 µmol, 5 mM), and <strong>[15839-70-0]GDP-Fuc</strong> (3.0 µmol, 2.5 mM) were incubated with 8.7 mU of the enzyme for four days at 37C. After desalting and gel filtration HPLC-run, the fucosylated product was separated from the non-fucosylated N-acetyl-chitotetraose by HPAEC using isocratic run with 40 mM NaOH (not shown). The purified product was desalted by ion exchange and was further purified by gel filtration HPLC yielding 744 nmol monofucosylated N-acetyl-chitotetraose. MALDI-TOF mass spectrometry of the product revealed that it was uncontaminated by N-acetyl-chitotetraose acceptor (not shown).

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 9

67
Glcβ1-3GalNAcβ1-4Glcβ1-3GalNAcol [ No CAS ]
[ 15839-70-0 ]
Glcβ1-3GalNAcβ1-4(Fucα1-3)Glcβ1-3GalNAcol [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	human milk fucosyltransferase(s);	Chondroitin sulfate (shark cartilage, Sigma) was cleaved by hyaluronidase (bovine testes, Sigma; chondroitin sulfates can be also cleaved with chondroitinases giving oligosaccharides with delta-uronic acid at non reducing end) to sulfated oligosaccharides such as[GlcAβ1-3(sulf-6)GalNAcβ1-4]nGlcAβ1-3(sulf-6)GalNAc. Fractions containing tetrasaccharide-like materials were purified and desulfated as essentially as described in (41). Tetrasaccharide and hexasaccharide fractions were purified by gel filtration and anion exhange chromatographies. Similar oligosaccharides were also produced by first desulfating and then cleaving by hyaluronidase and purifying the products. The GlcA-residues of the tetrasaccharide were reduced to Glc by EDAC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) and NaBH4. The reduced tetrasaccharide Glcβ1-3GalNAcβ1-4Glcβ1-3GalNAcol was purified and fucosylated using <strong>[15839-70-0]GDP-Fuc</strong> and human milk fucosyltransferase(s). The MALDI-TOF mass spectrometry revealed peaks at m/z 919.8 and m/z 935.8 corresponding to the product Glcβ1-3GalNAcβ1-4(Fucα1-3)Glcβ1-3GalNAcol (calc. m/z [M+Na]+ is 919.7 and m/z [M+K]+ is 935.7).

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 12

68
GlcNAcylβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAc [ No CAS ]
[ 15839-70-0 ]
GlcNacylβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAcβ1-4GlcNAc [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With manganese(ll) chloride;Fuc-TVI;	GlcNAcylβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAc, wherein Acyl is trans-9-octade-cenoyl, synthesis of the acceptor being described in (13), can be incubated with Fuc-TVI and MnCl2 under conditions described above for Fuc-TVI, but acceptor concentrations between 0.1-0.5 mM are preferred. The product GlcNA-cylβ1-4(Fucα1-3)GlcNAcβ1-4GlcNAcβ1-4GlcNAc is purified chromatographically and analyzed by NMR-spectroscopy and mass spectrometry.

Reference： [1]Patent: EP1228079,2004,B1 .Location in patent: Page 12

69
[ 15839-70-0 ]
[ 1093384-59-8 ]

Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 17593 - 17602

70
[ 15839-70-0 ]
[ 1093384-61-2 ]

Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 17593 - 17602

71
[ 18186-48-6 ]
[ 1093679-47-0 ]
[ 15839-70-0 ]

Reference： [1]Journal of the American Chemical Society,2008,vol. 130,p. 17593 - 17602

72
[ 15839-70-0 ]
3-aminopropyl-β-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-β-D-galactopyranosyl-(1->3)-α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-galactopyranoside [ No CAS ]
3-aminopropyl α-L-fucopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-β-D-galactopyranosyl-(1->3)-α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-glucopyranoside [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2008,vol. 350,p. 1717 - 1728

73
[ 1246842-76-1 ]
[ 15839-70-0 ]
β-D-galactopyranosyl-(1→4)-[α-L-fucopyranosyl (1→3)]-2-deoxy-2-acetamido-D-glucopyranosyl-β-1-azidopropane [ No CAS ]

Reference： [1]Glycobiology,2010,vol. 20,p. 1077 - 1088

74
[ 1340474-27-2 ]
[ 15839-70-0 ]
C₃₅H₄₇NO₁₇ [ No CAS ]

Reference： [1]Chemical Communications,2011,vol. 47,p. 11240 - 11242

75
[ 75598-07-1 ]
[ 15839-70-0 ]
C₂₀H₃₅NO₁₅ [ No CAS ]

Reference： [1]Glycobiology,2016,vol. 26,p. 493 - 500

76
6-deoxy-L-galactose [ No CAS ]
Guanosine 5'-triphosphate [ No CAS ]
[ 15839-70-0 ]

Reference： [1]Glycobiology,2016,vol. 26,p. 493 - 500
[2]Green Chemistry,2021,vol. 23,p. 2628 - 2633

77
C₉₃H₁₅₃N₈O₆₉^(1-)*Na⁽¹⁺⁾ [ No CAS ]
[ 15839-70-0 ]
α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→3)-(α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-α-D-mannopyranosyl-(1→6))-β-D-mannopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→4)-2-acetamido-2-deoxy-D-glucopyranose [ No CAS ]

Reference： [1]Chemical Science,2016,vol. 7,p. 4990 - 5001

78
[ 446-72-0 ]
[ 15839-70-0 ]
genistein fucoside [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With magnesium(II) chloride hexahydrate; glycosyltransferase from Arabidopsis thaliana; In aq. buffer; at 37.0℃; for 3h;pH 7.5;Enzymatic reaction;	General procedure: After checking the expression of protein, glycosylation reactions were carriedout using crude protein (AtUGT89C1) with genistein and sugars (T/UDP-α-Dglucose,UDP-α-D-galactose, UDP-α-D-glucuronic acid, UDP-α-D-N-acetyl-Dglucosamine,UDP-α-DN-acetylgalactosamine, dTDP-β-L-rhamnose, dTDP-α-2-deoxy-D-glucose, and <strong>[15839-70-0]GDP-β-L-fucose</strong>) as sugar donors. The reaction was carriedout in a total volume of 200 μL containing 100mMTris-HCl (pH 7.5) buffer, 2mMNDP sugar, 2 mM genistein, 10 mM MgCl2. 6H2 O, and 30 μL of crude protein(enzyme concentration was not calculated). The reaction mixtures were incubatedat 37C for 3 h. The reaction mixture lacking enzyme served as the control. Thereactionwas quenched by adding 400 μL chilled methanol and vortexing for severalminutes. Aliquots were centrifuged at 16,000×g to remove denatured proteins, andthe reaction products were monitored by HPLC coupled with a photodiode array(PDA), with 20 μL injected after proper dilution.

Reference： [1]Journal of Carbohydrate Chemistry,2016,vol. 35,p. 367 - 377

79
C₄₇H₆₁F₁₇N₆O₂₁S [ No CAS ]
[ 15839-70-0 ]
C₅₃H₇₁F₁₇N₆O₂₅S [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

80
C₄₇H₆₁F₁₇N₆O₂₃S [ No CAS ]
[ 15839-70-0 ]
C₅₃H₇₁F₁₇N₆O₂₇S [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

81
C₅₈H₇₈F₁₇N₇O₃₁S [ No CAS ]
[ 15839-70-0 ]
C₆₄H₈₈F₁₇N₇O₃₅S [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

82
[ 15839-70-0 ]
[ 209671-46-5 ]
C₂₆H₄₆N₄O₁₅ [ No CAS ]

Reference： [1]ACS Catalysis,2019,vol. 9,p. 11794 - 11800
[2]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

83
C₅₈H₇₈F₁₇N₇O₂₉S [ No CAS ]
[ 15839-70-0 ]
C₆₄H₈₈F₁₇N₇O₃₃S [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

84
[ 1609290-86-9 ]
[ 15839-70-0 ]
C₃₇H₆₃N₅O₂₃ [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

85
C₆₁H₈₄F₁₇N₇O₃₁S [ No CAS ]
[ 15839-70-0 ]
C₇₃H₁₀₄F₁₇N₇O₃₉S [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2018,vol. 360,p. 2313 - 2323

86
N^α-9-fluorenylmethyloxycarbonyl-O-{2-acetamido-2-deoxy-β-glucopyranosyl-(1→2)-[β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl]-(1→6)-α-D-mannopyranosyl}-L-threonine [ No CAS ]
[ 15839-70-0 ]
C₅₃H₇₅N₃O₂₉ [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2018,vol. 57,p. 9268 - 9273
Angew. Chem.,2018,vol. 130,p. 9412 - 9417,6

87
N^α-9-fluorenylmethyloxycarbonyl-O-{β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→2)-[2-acetamido-2-deoxy-β-glucopyranosyl-(1→6)]-α-D-mannopyranosyl}-L-threonine [ No CAS ]
[ 15839-70-0 ]
C₅₃H₇₅N₃O₂₉ [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2018,vol. 57,p. 9268 - 9273
Angew. Chem.,2018,vol. 130,p. 9412 - 9417,6

88
C₃₉H₅₂N₂O₂₀ [ No CAS ]
[ 15839-70-0 ]
C₄₅H₆₂N₂O₂₄ [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2018,vol. 57,p. 9268 - 9273
Angew. Chem.,2018,vol. 130,p. 9412 - 9417,6

Same Skeleton Products

Related Products

Historical Records

Similar Product of
[ 15839-70-0 ]

A1147700[ 148296-47-3 ]

(((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) methyl) ((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl) diphosphate sodium salt

Reason: Free-salt

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 15839-70-0 ] {[proInfo.proName]}

Quality Control of [ 15839-70-0 ]

Related Doc. of [ 15839-70-0 ]

Product Details of [ 15839-70-0 ]

Safety of [ 15839-70-0 ]

Application In Synthesis of [ 15839-70-0 ]

[ 15839-70-0 ] Synthesis Path-Downstream 1~88

Similar Product of [ 15839-70-0 ]

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Similar Product of
[ 15839-70-0 ]